Profound Medical Corp Share Price Toronto S.E.
Equities
PRN
CA74319B1067
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- CAD | - |
05-15 | Transcript : Profound Medical Corp. - Shareholder/Analyst Call | |
05-14 | Sector Update: Health Care Stocks Steady Premarket Tuesday | MT |
Sales 2024 * | 15.49M 11.32M 896M | Sales 2025 * | 41.52M 30.33M 2.4B | Capitalization | 282M 206M 16.28B |
---|---|---|---|---|---|
Net income 2024 * | -40M -29.22M -2.31B | Net income 2025 * | -31M -22.64M -1.79B | EV / Sales 2024 * | 18.2 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 6.78 x |
P/E ratio 2024 * |
-7.21
x | P/E ratio 2025 * |
-8.79
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.31% |
Latest transcript on Profound Medical Corp
Managers | Title | Age | Since |
---|---|---|---|
Arun Menawat
CEO | Chief Executive Officer | 69 | 03/06/15 |
Rashed Dewan
DFI | Director of Finance/CFO | 56 | 30/06/15 |
Mathieu Burtnyk
COO | Chief Operating Officer | 42 | 06/07/11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Arthur Rosenthal
BRD | Director/Board Member | 77 | 13/06/18 |
Director/Board Member | 67 | 13/06/18 | |
Cynthia Lavoie
BRD | Director/Board Member | - | 02/03/21 |
1st Jan change | Capi. | |
---|---|---|
+4.80% | 212B | |
+10.05% | 188B | |
+30.72% | 157B | |
+33.52% | 114B | |
+3.08% | 64.01B | |
+1.63% | 48.83B | |
-3.39% | 39.3B | |
+1.40% | 35.97B | |
+8.24% | 27B |
- Stock Market
- Equities
- PRN Stock
- PRN Stock